Get the Stockscreener App
0.4421
12.46%
-0.0629
After Hours:
.44
-0.0021
-0.48%
Cyclacel Pharmaceuticals Inc Stock (CYCC) Forecast
The Cyclacel Pharmaceuticals Inc (CYCC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2444, representing a +181.47% increase from the current price of $0.4421. The highest analyst price target is $2.1912, and the lowest is $0.2975.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CYCC Price Target
Average 4.8063
(+987.14% Upside)
Is Cyclacel Pharmaceuticals Inc (CYCC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.62 | Buy |
| STOCH(9,6) | 2.1911 | Buy |
| STOCHRSI(14) | 13.84 | Buy |
| MACD(12,26) | -0.1245 | Sell |
| ADX(14) | 33.53 | Buy |
| William %R | -99.54 | Buy |
| CCI(14) | -97.59 | Neutral |
Buy: 5
Sell: 1
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7023
Sell
|
0.6807
Sell
|
| MA20 |
0.8462
Sell
|
0.7945
Sell
|
| MA50 |
0.9507
Sell
|
0.9746
Sell
|
| MA100 |
1.2516
Sell
|
1.2074
Sell
|
| MA200 |
1.7441
Sell
|
1.3029
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CYCC could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 11 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on CYCC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.62 indicates that CYCC is oversold. This indicates that CYCC price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 2.1911 indicates that CYCC is oversold. This indicates that CYCC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.84 indicates that CYCC is oversold. This suggests that CYCC price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.53 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.59 indicates that CYCC is still oversold but not to an extreme extent.
Long-term CYCC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cyclacel Pharmaceuticals Inc financial reports and earnings history, Cyclacel Pharmaceuticals Inc (CYCC) stock could reach $11.00 by 2030, $11.91 by 2040 and $27.81 by 2050. See the projected annual prices until 2050 of the Cyclacel Pharmaceuticals Inc stock below:
- Cyclacel Pharmaceuticals Inc (CYCC) is expected to reach an average price of $5.7348 in 2035, with a high prediction of $5.7309 and a low estimate of $5.6338. This indicates an $1,197% rise from the last recorded price of $0.4421.
- Cyclacel Pharmaceuticals Inc (CYCC) stock is projected to chart a bullish course in 2040, with an average price target of $11.64, representing an $2,533% surge from its current level. The forecast ranges from a conservative $11.69 to a sky-high $11.91.
- Our analysts predict Cyclacel Pharmaceuticals Inc (CYCC) to jump 4,238% by 2045, soaring from $19.19 to an average price of $19.18, potentially reaching $19.19. While $19.19 is the low estimate, the potential upside is significant.
- Cyclacel Pharmaceuticals Inc (CYCC) stock is expected to climb by 2050, reaching an average of $27.66, a $6,157% jump from its current level. However, a wide range of estimates exists, with high and low targets of $27.81 and $27.87, respectively, highlighting the market's uncertainty.
Cyclacel Pharmaceuticals Inc Stock (CYCC) Year by Year Forecast
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2024
Our forecast for CYCC stock price in 2024 now indicates an average price target of $4.716 with a high forecast of $9.1345 and a low forecast of $0.2975. The average prediction reflects an increase of +966.73% from the last recorded price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.3805 | $0.2975 | $2.1912 | +212.25% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2025
Cyclacel Pharmaceuticals Inc Stock (CYCC) is expected to reach an average price of $4.8063 in 2025, with a high prediction of $9.6094 and a low estimate of $0.0031. This indicates an +987.14% rise from the last recorded price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.6586 | $0.0031 | $5.6117 | +501.35% |
| February, 2025 | $3.5295 | $2.8898 | $9.4878 | +698.35% |
| March, 2025 | $0.7104 | $0.4084 | $5.2147 | +60.69% |
| April, 2025 | $1.9375 | $0.3396 | $1.7355 | +338.25% |
| May, 2025 | $0.8706 | $1.2606 | $9.6094 | +96.92% |
| June, 2025 | $5.3757 | $5.4357 | $5.3681 | +1,116% |
| July, 2025 | $4.7395 | $4.5232 | $4.4195 | +972.05% |
| August, 2025 | $4.7646 | $4.7459 | $4.5646 | +977.73% |
| September, 2025 | $4.3297 | $4.3847 | $4.5934 | +879.36% |
| October, 2025 | $5.6386 | $4.8173 | $5.0748 | +1,175% |
| November, 2025 | $5.1487 | $5.3487 | $5.4224 | +1,065% |
| December, 2025 | $5.3826 | $4.885 | $5.0475 | +1,118% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2026
The predicted value for Cyclacel Pharmaceuticals Inc (CYCC) in 2026 is set at an average of $2.6558. Estimates vary from a peak of $5.2199 to a trough of $0.0917, indicating an +500.72% surge from the present price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.6677 | $5.0977 | $5.2199 | +955.80% |
| February, 2026 | $4.1528 | $4.3228 | $4.4964 | +839.33% |
| March, 2026 | $0.9179 | $0.7891 | $1.5021 | +107.62% |
| April, 2026 | $0.3983 | $0.0917 | $3.277 | -9.92% |
| May, 2026 | $0.4032 | $0.5568 | $0.9632 | -8.81% |
| June, 2026 | $0.4619 | $0.7332 | $0.5344 | +4.49% |
| July, 2026 | $0.9158 | $0.9283 | $0.8258 | +107.15% |
| August, 2026 | $0.5609 | $0.7134 | $0.3509 | +26.87% |
| September, 2026 | $1.6248 | $1.3714 | $1.5648 | +267.51% |
| October, 2026 | $2.1899 | $2.2935 | $2.0099 | +395.33% |
| November, 2026 | $1.735 | $1.965 | $2.1474 | +292.44% |
| December, 2026 | $1.7388 | $1.5925 | $1.4813 | +293.31% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cyclacel Pharmaceuticals Inc (CYCC) is $3.0625, with a high forecast of $4.4898 and a low forecast of $1.6352. This indicates an +592.71% increase from the last price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8339 | $1.6352 | $1.5076 | +314.82% |
| February, 2027 | $2.559 | $1.9215 | $1.899 | +478.83% |
| March, 2027 | $3.2329 | $3.0133 | $2.9229 | +631.26% |
| April, 2027 | $2.868 | $2.8692 | $2.668 | +548.72% |
| May, 2027 | $3.1131 | $3.2431 | $3.1443 | +604.16% |
| June, 2027 | $2.707 | $3.0106 | $2.8582 | +512.30% |
| July, 2027 | $3.0321 | $3.052 | $2.8545 | +585.83% |
| August, 2027 | $4.0072 | $2.9731 | $3.8572 | +806.39% |
| September, 2027 | $4.591 | $4.1059 | $4.3123 | +938.46% |
| October, 2027 | $4.3761 | $4.5573 | $4.4898 | +889.85% |
| November, 2027 | $4.3812 | $4.3449 | $4.4224 | +891.00% |
| December, 2027 | $3.8451 | $4.2151 | $4.26 | +769.73% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2028
In 2028, Cyclacel Pharmaceuticals Inc (CYCC) is projected to reach an average price of $3.5633, with a high projection of $3.9429 and a low estimate of $3.1837. This indicates an +706.00% rise from the last price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.5802 | $3.7202 | $3.5814 | +709.81% |
| February, 2028 | $3.6853 | $3.629 | $3.6604 | +733.59% |
| March, 2028 | $3.5992 | $3.6092 | $3.7428 | +714.10% |
| April, 2028 | $4.0283 | $3.7867 | $3.901 | +811.16% |
| May, 2028 | $3.9743 | $4.0196 | $3.9429 | +798.96% |
| June, 2028 | $3.6032 | $3.6732 | $3.9269 | +715.02% |
| July, 2028 | $3.4284 | $3.4935 | $3.5808 | +675.48% |
| August, 2028 | $3.6492 | $3.4171 | $3.5103 | +725.42% |
| September, 2028 | $3.5844 | $3.6073 | $3.5907 | +710.76% |
| October, 2028 | $3.5323 | $3.5235 | $3.5161 | +698.98% |
| November, 2028 | $3.2463 | $3.2661 | $3.4307 | +634.28% |
| December, 2028 | $3.1822 | $3.1837 | $3.176 | +619.80% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2029
The 2029 price forecast for Cyclacel Pharmaceuticals Inc Stock (CYCC) is $3.9312 on average, with a high prediction of $7.856 and a low estimate of $0.00646. This represents an +789.22% increase from the previous price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9462 | $3.0032 | $3.1134 | +566.41% |
| February, 2029 | $3.1163 | $3.014 | $2.9576 | +604.89% |
| March, 2029 | $3.0405 | $3.0379 | $3.0254 | +587.74% |
| April, 2029 | $2.6165 | $2.8704 | $2.9942 | +491.84% |
| May, 2029 | $2.5434 | $2.5494 | $2.5291 | +475.29% |
| June, 2029 | $2.6896 | $2.7075 | $2.7089 | +508.36% |
| July, 2029 | $0.1646 | $0.2645 | $2.6202 | -62.77% |
| August, 2029 | $0.4384 | $0.5621 | $0.8779 | -0.83% |
| September, 2029 | $0.0965 | $0.00646 | $0.5265 | -78.18% |
| October, 2029 | $0.2094 | $0.00901 | $0.5601 | -52.63% |
| November, 2029 | $0.4925 | $0.335 | $0.1826 | +11.40% |
| December, 2029 | $8.678 | $0.2888 | $7.856 | +1,863% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2030
Cyclacel Pharmaceuticals Inc Stock (CYCC) is expected to reach an average price of $9.8786 in 2030, with a high forecast of $13.67 and a low forecast of $6.0875. This signifies an +2,134% surge from the last price of $0.4421.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.70 | $9.3935 | $11.00 | +2,547% |
| February, 2030 | $9.6999 | $11.49 | $11.13 | +2,094% |
| March, 2030 | $10.48 | $11.24 | $10.37 | +2,271% |
| April, 2030 | $13.80 | $11.38 | $12.60 | +3,021% |
| May, 2030 | $13.28 | $13.64 | $13.08 | +2,904% |
| June, 2030 | $14.23 | $13.97 | $13.36 | +3,119% |
| July, 2030 | $10.52 | $12.92 | $13.67 | +2,280% |
| August, 2030 | $9.9362 | $8.9326 | $9.6775 | +2,147% |
| September, 2030 | $1.8424 | $7.2204 | $9.0657 | +316.73% |
| October, 2030 | $5.1081 | $6.0875 | $4.9081 | +1,055% |
| November, 2030 | $10.36 | $6.2457 | $8.1783 | +2,243% |
| December, 2030 | $12.41 | $12.07 | $11.71 | +2,706% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):